Evan David Seigerman
Stock Analyst at BMO Capital
(4.04)
Main Sectors:
Top Industries:
16 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ABBV AbbVie | Maintains: Outperform | 215 240 | 233.87 | 2.62% | 8 | Sep 12, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Outperform | 600 640 | 600 | 6.67% | 8 | Aug 4, 2025 | |
REPL Replimune Group | Downgrades: Underperform | 27 2 | 4.73 | -57.72% | 4 | Jul 23, 2025 | |
NGNE Neurogene | Maintains: Outperform | 22 26 | 22.34 | 16.38% | 2 | Jun 12, 2025 | |
MRUS Merus | Maintains: Outperform | 96 110 | 94.29 | 16.66% | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 28 | 21.8 | 28.44% | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 10 | 9.61 | 4.06% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 105 64 | 59.64 | 7.31% | 6 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 105 96 | 89.17 | 7.66% | 4 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 362 346 | 297.89 | 16.15% | 4 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 52 57 | n/a | n/a | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 100 | 27.28 | 266.57% | 2 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 36 | 27.36 | 31.58% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 31 72 | n/a | n/a | 4 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | 5.56 | -46.04% | 1 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 369 396 | 840.01 | -52.86% | 1 | Sep 6, 2022 |